![Andrew Ratz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 156 803 $ au 31/08/2026
Dr. Andrew Ratz is a Chief Technical Operations Officer at Neurocrine Biosciences, Inc. Dr. Ratz was previously employed as a Senior Vice President & Head-Drug Delivery by Eli Lilly & Co. He received his undergraduate degree from Indiana University and a doctorate degree from Harvard University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/03/2026 | 1 018 ( 0 % ) | 156 803 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 17/03/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
